Showing results (4381-4390 of 9,345) with videos related to
Sort By:
Pageof 935
Journal of Biomolecular Structure & Dynamics|May 24, 2024
Designing of xanthine-based DPP-4 inhibitors: a structure-guided alignment dependent Multifacet 3D-QSAR modeling, and molecular dynamics simulation studyPriya Bisht, Priyadarshi Gautam, Arka Bhattacharya, et al.Journal of Biomolecular Structure & Dynamics|April 29, 2024
Redesigning the kinetics of lysozyme amyloid aggregation by cephalosporin moleculesShivani A Muthu, Afnaan Qureshi, Rahul Sharma, et al.Journal of Biomolecular Structure & Dynamics|April 30, 2024
An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastomaAdarsh Gopinathan, Runali Sankhe, Ekta Rathi, et al.Journal of Biomolecular Structure & Dynamics|November 14, 2023
Identification of potent inhibitors for Leishmania donovani homoserine kinase: an integrated in silico and kinetic studyMohini Soni, Gaurava Srivastava, Karthik Ramalingam, et al.Journal of Biomolecular Structure & Dynamics|November 14, 2023
A novel therapeutic approach to prevent Helicobacter pylori induced gastric cancer using networking biology, molecular docking, and simulation approachesNadeem Khan, Bushra Rehman, Taghreed N Almanaa, et al.Journal of Biomolecular Structure & Dynamics|November 10, 2023
Drug repurposing for targeting fibronectin in treatment of endometriosis and cancersSoodeh Mahdian, Ashraf Moini, Fereshteh Esfandiari, et al.Journal of Biomolecular Structure & Dynamics|November 10, 2023
Network pharmacology analysis of Plumbago zeylanica to identify the therapeutic targets and molecular mechanisms involved in ameliorating hemorrhoidsArijit Nandi, Tanzeem Nigar, Anwesha Das, et al.Journal of Biomolecular Structure & Dynamics|November 10, 2023
HDAC inhibition by Nigella sativa L. sprouts extract in hepatocellular carcinoma: an approach to study anti-cancer potentialAbdullah Algaissi, Heena Tabassum, Elhan Khan, et al.Journal of Biomolecular Structure & Dynamics|November 10, 2023
Inter-BRCT linker is probably the most intolerant region of the BRCA1 BRCT domainFatemeh Yadegari, Leila Farahmand, Rezvan Esmaeili, et al.Journal of Biomolecular Structure & Dynamics|November 8, 2023
Derivates of 1,6-dihyadroazaazulenes as inhibitors of tyrosine kinases BCR-ABL1 wild type and mutant T315I: a molecular dynamics approachManuel de Jesus Solís-Hernández, Juan Pedro Palomares-Báez, Rafael Herrera-Bucio, et al.Pageof 935